Morbidity in 565 type 2 diabetic patients according to stage of nephropathy

Journal of Diabetes and its Complications

Volumn 12, Issue 2, 1998, Pages 103-109

  Schleiffer, Thomas ^a   Hölken, Harald ^a   Brass, Horst ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; AMPUTATION; ARTICLE; BLINDNESS; CATARACT; DIABETIC FOOT; DIABETIC NEPHROPATHY; DIALYSIS; DISEASE SEVERITY; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INTERNAL CAROTID ARTERY OCCLUSION; KIDNEY FUNCTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; PROTEINURIA; STROKE;

EID: 0345404471     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(97)00003-2     Document Type: Article

References (30)

1. Gall MA, Borch-Johnsen K, Hougaard P, Nielsen FS, Parving HH Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes. 44:1995;1303-1309.
2. Stiegler H, Standl E, Schulz K, Roth R, Lehmacher W Frequency, risk profile and mortality of a random sample of albuminuric type 2 diabetic patients. A 5-year prospective study in general practice. Diab Stoffw. 2:1993;62-67.
3. Held P, Port FK, Gaylin DS, Wolfe RA The 1993 United States Renal Data System annual data report - excerpts. Patient survival and causes of death. Am J Kidney Dis. 22(suppl 2):1993;46-57.
4. Koch M, Thomas B, Tschöpe W, Ritz E Survival and predictors of death in dialysed diabetics. Diabetologia. 36:1993;1113-1117.
5. Brown JH, Hunt LP, Vites NP, Short CD, Gokal R, Mallick NP Comparative mortality from cardiovascular disease in patients with chronic renal failure. Nephrol Dial Transplant. 9:1994;1136-1142.
6. Sowers JR, Epstein M Diabetes mellitus and associated hypertension, vascular disease, and nephropathy - An update. Hypertension. 26:1995;869-879.
7. Rossing P, Hougaard P, Borch-Johnsen K, Parving HH Predictors of mortality in insulin dependent diabetes. 10 year observational follow up study BMJ. 313:1996;779-784.
8. Mogensen CE Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med. 310:1984;356-360.
9. Neil A, Hawkins M, Potok M, Thorogood M, Cohen D, Mann J A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM. Diabetes Care. 16:1993;996-1003.
10. Nelson RG, Pettitt DJ, Carraher MJ, Baird R, Knowler WC Effect of proteinuria on mortality in NIDDM. Diabetes. 37:1988;1499-1504.
11. Mogensen CE Definition of diabetic renal disease in insulin-dependent diabetes mellitus based on renal function tests. Mogensen CE The Kidney and Hypertension in Diabetes Mellitus. 1994;1-14 Kluwer, Boston. 2nd edition.
12. Gall MA, Rossing P, Skott P, Damsbo P, Vaag A, Bech K, Dejgaard A, Lauritzen M, Lauritzen E, Hougard P, Beck-Nielsen H, Parving HH Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 diabetic patients. Diabetologia. 34:1991;655-661.
13. Stiegler H, Standl E, Schulz K, Roth R, Lehmacher W Morbidity, mortality, and albuminuria in type 2 diabetic patients. A three-year prospective study of a random cohort in general practice Diabetic Med. 9:1992;646-653.
14. Wang SL, Head J, Stevens L, Fuller JH, World Health Organization Multinational Study Group Excess mortality and its relation to hypertension and proteinuria in diabetic patients. Diabetes Care. 19:1996;305-312.
15. MacLeod JM, Lutale J, Marshall SM Albumin excretion and vascular deaths in NIDDM. Diabetologia. 38:1995;610-616.
16. Braun D, Unger H, Wagner A, Henrichs HR Prevalence of diabetic retinopathy, nephropathy, and arterial hypertension in relation to the duration of diabetes mellitus. Diab Stoffw. 3:1994;333-338.
17. Parving HH, Gall MA, Skott P, Jorgensen HE, Lokkegaard H, Jorgensen F, Nielsen B, Larsen S Prevalence and causes of albuminuria in NIDDM patients. Kidney Int. 41:1992;758-762.
18. Krolewski AS, Laffel LMB, Krolewski M, Quinn M, Warram JH Glycosylated hemoglobin and the risk of microalbuminuria in patients with IDDM. N Engl J Med. 332:1995;1251-1255.
19. Chaturvedi N, Fuller JH Glycosylated hemoglobin and the risk of microalbuminuria in patients with IDDM [Letter]. N Engl J Med. 333:1995;940.
20. UK Prospective Diabetes Study Group UK Prospective Diabetes Study 16 - Overview of 6 years' therapy of type 2 diabetes. A progressive disease Diabetes. 44:1995;1249-1258.
21. Biesenbach G, Zazgornik J High mortality and poor quality of life during predialysis period in type 2 diabetic patients with diabetic nephropathy. Renal Failure. 16:1994;263-272.
22. Makita Z, Yanagisawa K, Kuwajima S, Yoshioka N, Atsumi T, Hasunuma Y, Koike T Advanced glycation endproducts and diabetic nephropathy. J Diabet Complications. 9:1995;265-268.
23. Bucala R, Makita Z, Vega G, Grundy S, Koschinsky T, Cerami A, Vlassara H Modification of low density lipoprotein by advanced glycation endproducts contributes to the dyslipidemia of diabetes and renal insufficiency. Proc Natl Acad Sci USA. 91:1994;9441-9445.
24. Chen JW, Gall MA, Yokoyama H, Jensen JS, Deckert M, Parving HH Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy. Diabetes Care. 19:1996;130-134.
25. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia. 32:1989;219-226.
26. Nielsen FS, Rossing P, Bang LE, Svendsen TL, Gall MA, Smidt UM, Parving HH On the mechanisms of blunted nocturnal decline in arterial blood pressure in NIDDM patients with diabetic nephropathy. Diabetes. 44:1995;783-789.
27. Schleiffer T, Klooker P, Brass H 24-hour ambulatory blood pressure measurement in non-insulin-dependent diabetic patients with and without nephropathy. Z Kardiol. 81(suppl 2):1992;75-78.
28. Sawicki PT, Mühlhauser I, Didjurgeit U, Reimann M, Bender R, Berger M Mortality and morbidity in treated hypertensive type 2 diabetic patients with micro- and macroproteinuria. Diabetic Med. 12:1995;893-898.
29. McNally PG, Cooper ME Antihypertensive treatment in NIDDM with special reference to abnormal albuminuria. Mogensen CE The Kidney and Hypertension in Diabetes Mellitus. 1994;341-351 Kluwer, Boston. 2nd edition.
30. Viberti GC, Mogensen CE, Passa P, Bilous R, Mangili R St. Vincent Declaration 1994. Guidelines for the prevention of diabetic renal failure Mogensen CE The Kidney and Hypertension in Diabetes Mellitus. 1994;515-527 Kluwer, Boston. 2nd edition.